Review



microvue complement ic3b eia kit  (Quidel)


Bioz Verified Symbol Quidel is a verified supplier
Bioz Manufacturer Symbol Quidel manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Quidel microvue complement ic3b eia kit
    Microvue Complement Ic3b Eia Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 106 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/pmc12595093__mmc2-33-31-36?v=Quidel
    Average 96 stars, based on 106 article reviews
    microvue complement ic3b eia kit - by Bioz Stars, 2026-07
    96/100 stars

    Images



    Similar Products

    96
    Quidel microvue complement ic3b eia kit
    Microvue Complement Ic3b Eia Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/pmc12595093__mmc2-33-31-36?v=Quidel
    Average 96 stars, based on 1 article reviews
    microvue complement ic3b eia kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    ic3b  (Quidel)
    96
    Quidel ic3b
    Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of <t>iC3b</t> and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).
    Ic3b, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/pm40554195-64-3-12?v=Quidel
    Average 96 stars, based on 1 article reviews
    ic3b - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Quidel microvue ic3b eia kit
    Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of <t>iC3b</t> and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).
    Microvue Ic3b Eia Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/pm40554195-64-7-12?v=Quidel
    Average 96 stars, based on 1 article reviews
    microvue ic3b eia kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Quidel ic3b elisa
    Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of <t>iC3b</t> and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).
    Ic3b Elisa, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/us12257290-211-1-22?v=Quidel
    Average 96 stars, based on 1 article reviews
    ic3b elisa - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    MyBiosource Biotechnology elisa assays ic3b
    Exposure to severe hypoxia enhanced complement system activation within the MSCs. The expression level of the complement component markers C3b, <t>iC3b</t> and C5-C9 were analyzed using Elisa assay. By comparing the expression levels of the complement components C3b, iC3b, and C5-C9 in MSCs under hypoxic and normoxic conditions, the ELISA assay can identify dysregulation of complement activation in response to severe hypoxia. A C3b expression levels were significantly increased in hypoxic MSCs compared to control. B iC3b expression levels decreased significantly in hypoxic MSCs compared to normoxic cells. D C5-C9 expression levels were significantly higher in hypoxic MSCs compared to control. (*p < 0.05 vs. control, n = 3)
    Elisa Assays Ic3b, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/pmc11711716-52-18-19?v=MyBiosource+Biotechnology
    Average 90 stars, based on 1 article reviews
    elisa assays ic3b - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    MyBiosource Biotechnology elisa assays for ic3b
    Exposure to severe hypoxia enhanced complement system activation within the MSCs. The expression level of the complement component markers C3b, <t>iC3b</t> and C5-C9 were analyzed using Elisa assay. By comparing the expression levels of the complement components C3b, iC3b, and C5-C9 in MSCs under hypoxic and normoxic conditions, the ELISA assay can identify dysregulation of complement activation in response to severe hypoxia. A C3b expression levels were significantly increased in hypoxic MSCs compared to control. B iC3b expression levels decreased significantly in hypoxic MSCs compared to normoxic cells. D C5-C9 expression levels were significantly higher in hypoxic MSCs compared to control. (*p < 0.05 vs. control, n = 3)
    Elisa Assays For Ic3b, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/pm39485618-63-0-19?v=MyBiosource+Biotechnology
    Average 90 stars, based on 1 article reviews
    elisa assays for ic3b - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    Quidel microvue ic3b a006 elisa kit
    Exposure to severe hypoxia enhanced complement system activation within the MSCs. The expression level of the complement component markers C3b, <t>iC3b</t> and C5-C9 were analyzed using Elisa assay. By comparing the expression levels of the complement components C3b, iC3b, and C5-C9 in MSCs under hypoxic and normoxic conditions, the ELISA assay can identify dysregulation of complement activation in response to severe hypoxia. A C3b expression levels were significantly increased in hypoxic MSCs compared to control. B iC3b expression levels decreased significantly in hypoxic MSCs compared to normoxic cells. D C5-C9 expression levels were significantly higher in hypoxic MSCs compared to control. (*p < 0.05 vs. control, n = 3)
    Microvue Ic3b A006 Elisa Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ic3b+elisa/us12116606-1156-12-17?v=Quidel
    Average 96 stars, based on 1 article reviews
    microvue ic3b a006 elisa kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of iC3b and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).

    Journal: Journal of neuroimmunology

    Article Title: Contribution of activated complements and CD59 to the pathophysiology of Rasmussen syndrome.

    doi: 10.1016/j.jneuroim.2025.578667

    Figure Lengend Snippet: Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of iC3b and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).

    Article Snippet: CSF levels of iC3b were measured using MicroVue iC3b EIA Kit (A006, Quidel, San Diego, USA).

    Techniques: Membrane, Control

    Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of iC3b and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).

    Journal: Journal of neuroimmunology

    Article Title: Contribution of activated complements and CD59 to the pathophysiology of Rasmussen syndrome.

    doi: 10.1016/j.jneuroim.2025.578667

    Figure Lengend Snippet: Fig. 4. Activated complements and seizure frequency at examination of CSF. A. CSF levels of C5a and seizure frequencies at the examination. B. CSF levels of iC3b and seizure frequencies at the examination. C. CSF levels of soluble membrane attack complex (sMAC) and seizure frequencies at the examination. D. CSF levels of CD59 and seizure frequencies at the examination. CSF level of CD59 in RS patients was different among groups of seizure frequencies (p = 0.0317). The CSF level of CD59 in RS patients with daily seizure was significantly lower than that in RS patients of seizure control (p = 0.0097).

    Article Snippet: CSF levels of iC3b were measured using MicroVue iC3b EIA Kit (A006, Quidel, San Diego, USA).

    Techniques: Membrane, Control

    Exposure to severe hypoxia enhanced complement system activation within the MSCs. The expression level of the complement component markers C3b, iC3b and C5-C9 were analyzed using Elisa assay. By comparing the expression levels of the complement components C3b, iC3b, and C5-C9 in MSCs under hypoxic and normoxic conditions, the ELISA assay can identify dysregulation of complement activation in response to severe hypoxia. A C3b expression levels were significantly increased in hypoxic MSCs compared to control. B iC3b expression levels decreased significantly in hypoxic MSCs compared to normoxic cells. D C5-C9 expression levels were significantly higher in hypoxic MSCs compared to control. (*p < 0.05 vs. control, n = 3)

    Journal: Tissue Engineering and Regenerative Medicine

    Article Title: Hypoxic Stress Induces Complement-Mediated Lysis of Mesenchymal Stem Cells by Downregulating Factor H and CD59

    doi: 10.1007/s13770-024-00678-6

    Figure Lengend Snippet: Exposure to severe hypoxia enhanced complement system activation within the MSCs. The expression level of the complement component markers C3b, iC3b and C5-C9 were analyzed using Elisa assay. By comparing the expression levels of the complement components C3b, iC3b, and C5-C9 in MSCs under hypoxic and normoxic conditions, the ELISA assay can identify dysregulation of complement activation in response to severe hypoxia. A C3b expression levels were significantly increased in hypoxic MSCs compared to control. B iC3b expression levels decreased significantly in hypoxic MSCs compared to normoxic cells. D C5-C9 expression levels were significantly higher in hypoxic MSCs compared to control. (*p < 0.05 vs. control, n = 3)

    Article Snippet: ELISA assays were performed to detect the expression and activity of C3b (Genochem world SL., lot # GW3605Hu), iC3b (My BioSource, Cat # MBS1603937), and MAC complex (C5b-C9) (GenoChem, Cat # GW3858Hu), following the manufacturer's instructions.

    Techniques: Activation Assay, Expressing, Enzyme-linked Immunosorbent Assay, Control